313 related articles for article (PubMed ID: 2454957)
1. Tumour associated antigens in diagnosis of serous effusions.
Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
[TBL] [Abstract][Full Text] [Related]
2. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in the diagnosis of malignant serous effusions.
Cascinu S; Del Ferro E; Barbanti I; Ligi M; Fedeli A; Catalano G
Am J Clin Oncol; 1997 Jun; 20(3):247-50. PubMed ID: 9167746
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers in the diagnosis of ascitic and pleural puncture fluids].
Mezger J; Lamerz R; Arnholdt H; Huhn D; Wilmanns W
Onkologie; 1986 Feb; 9(1):11-6. PubMed ID: 3523341
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
[TBL] [Abstract][Full Text] [Related]
7. [Immunochemical approach to clinical cytology by demonstration of tumor markers using enzyme-labeled antibody technic].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan No Rinsho; 1986 Jul; 32(8):895-9. PubMed ID: 2427754
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy.
Gandhi AK; Nayar M; Bihari N; Chandra M
Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212
[TBL] [Abstract][Full Text] [Related]
9. Tumor markers in pleural effusions.
Topolcan O; Holubec L; Polivkova V; Svobodova S; Pesek M; Treska V; Safranek J; Hajek T; Bartunek L; Rousarova M; Finek J
Anticancer Res; 2007; 27(4A):1921-4. PubMed ID: 17649796
[TBL] [Abstract][Full Text] [Related]
10. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
[TBL] [Abstract][Full Text] [Related]
11. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
Orell SR; Dowling KD
Acta Cytol; 1983; 27(6):625-9. PubMed ID: 6196931
[TBL] [Abstract][Full Text] [Related]
12. CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers.
Ferroni P; Szpak C; Greiner JW; Simpson JF; Guadagni F; Johnston WW; Colcher D
Int J Cancer; 1990 Sep; 46(3):445-51. PubMed ID: 2394511
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum CA 125 levels in patients with benign ascitic or pleural effusions.
Mezger J; Wilmanns W; Lamerz R
Tumour Biol; 1988; 9(1):47-52. PubMed ID: 3163160
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
Ghosh AK; Mason DY; Spriggs AI
J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated antigens in effusions of malignant and benign origin.
Ammon A; Eiffert H; Reil S; Beyer JH; Droese M; Hiddemann W
Clin Investig; 1993 Jun; 71(6):437-44. PubMed ID: 8353402
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of the tumour markers CEA, CA 15-3 and CA 125 in malignant effusions in breast cancer.
Kandylis K; Vassilomanolakis M; Baziotis N; Papadimitriou A; Tsoussis S; Ferderigou A; Efremidis AP
Ann Oncol; 1990 Nov; 1(6):435-8. PubMed ID: 2083187
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of tumoural markers in pleural effusions.
Ustün H; Borazan A; Bilgiçli N; Yilmaz A
Int J Clin Pract; 2004 Jan; 58(1):22-5. PubMed ID: 14994966
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of three tumor markers determined in pleural effusions.
Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic value of carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in pleural effusion].
Chen TM; Chang SC; Lu JY; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 1987 Oct; 40(4):375-82. PubMed ID: 3502856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
